메뉴 건너뛰기




Volumn 34, Issue 4-5, 2010, Pages 283-287

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone;Triple thérapie avec acide ursodésoxycholique, budésonide et mycophénolate dans les formes sévères de cirrhose biliaire primitive résistantes à l'acide ursodésoxycholique

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; BUDESONIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; URSODEOXYCHOLIC ACID;

EID: 77953961681     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.02.004     Document Type: Article
Times cited : (55)

References (28)
  • 1
    • 14944361288 scopus 로고    scopus 로고
    • The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
    • Corpechot C., Carrat F., Bahr A., Chretien Y., Poupon R.E., Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005, 128(2):297-303.
    • (2005) Gastroenterology , vol.128 , Issue.2 , pp. 297-303
    • Corpechot, C.1    Carrat, F.2    Bahr, A.3    Chretien, Y.4    Poupon, R.E.5    Poupon, R.6
  • 2
    • 33644854254 scopus 로고    scopus 로고
    • Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
    • Pares A., Caballeria L., Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006, 130(3):715-720.
    • (2006) Gastroenterology , vol.130 , Issue.3 , pp. 715-720
    • Pares, A.1    Caballeria, L.2    Rodes, J.3
  • 3
    • 33748375153 scopus 로고    scopus 로고
    • Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients
    • ter Borg P.C., Schalm S.W., Hansen B.E., van Buuren H.R. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 2006, 101(9):2044-2050.
    • (2006) Am J Gastroenterol , vol.101 , Issue.9 , pp. 2044-2050
    • ter Borg, P.C.1    Schalm, S.W.2    Hansen, B.E.3    van Buuren, H.R.4
  • 4
    • 35248893940 scopus 로고    scopus 로고
    • Ursodeoxycholic acid for the treatment of primary biliary cirrhosis
    • Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007, 357(15):1524-1529.
    • (2007) N Engl J Med , vol.357 , Issue.15 , pp. 1524-1529
    • Lindor, K.1
  • 5
    • 25144474552 scopus 로고    scopus 로고
    • Primary biliary cirrhosis
    • Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353(12):1261-1273.
    • (2005) N Engl J Med , vol.353 , Issue.12 , pp. 1261-1273
    • Kaplan, M.M.1    Gershwin, M.E.2
  • 6
    • 38549123480 scopus 로고    scopus 로고
    • Medical treatment of cholestatic liver disease
    • [viii]
    • Paumgartner G., Pusl T. Medical treatment of cholestatic liver disease. Clin Liver Dis 2008, 12(1):53-80. [viii].
    • (2008) Clin Liver Dis , vol.12 , Issue.1 , pp. 53-80
    • Paumgartner, G.1    Pusl, T.2
  • 7
    • 0036182838 scopus 로고    scopus 로고
    • Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients
    • Corpechot C., Carrat F., Poupon R., Poupon R.E. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002, 122(3):652-658.
    • (2002) Gastroenterology , vol.122 , Issue.3 , pp. 652-658
    • Corpechot, C.1    Carrat, F.2    Poupon, R.3    Poupon, R.E.4
  • 8
    • 51349157245 scopus 로고    scopus 로고
    • Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
    • Corpechot C., Abenavoli L., Rabahi N., Chretien Y., Andreani T., Johanet C., et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 2008, 48(3):871-877.
    • (2008) Hepatology , vol.48 , Issue.3 , pp. 871-877
    • Corpechot, C.1    Abenavoli, L.2    Rabahi, N.3    Chretien, Y.4    Andreani, T.5    Johanet, C.6
  • 9
    • 55249105177 scopus 로고    scopus 로고
    • Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment
    • Huet P.M., Vincent C., Deslaurier J., Cote J., Matsutami S., Boileau R., et al. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology 2008, 135(5):1552-1560.
    • (2008) Gastroenterology , vol.135 , Issue.5 , pp. 1552-1560
    • Huet, P.M.1    Vincent, C.2    Deslaurier, J.3    Cote, J.4    Matsutami, S.5    Boileau, R.6
  • 10
    • 62949221007 scopus 로고    scopus 로고
    • Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid
    • Kuiper E.M., Hansen B.E., de Vries R.A., den Ouden-Muller J.W., van Ditzhuijsen T.J., Haagsma E.B., et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 2009, 136(4):1281-1287.
    • (2009) Gastroenterology , vol.136 , Issue.4 , pp. 1281-1287
    • Kuiper, E.M.1    Hansen, B.E.2    de Vries, R.A.3    den Ouden-Muller, J.W.4    van Ditzhuijsen, T.J.5    Haagsma, E.B.6
  • 11
    • 10344254306 scopus 로고    scopus 로고
    • A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group
    • Poupon R.E., Huet P.M., Poupon R., Bonnand A.M., Nhieu J.T., Zafrani E.S. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Hepatology 1996, 24(5):1098-1103.
    • (1996) Hepatology , vol.24 , Issue.5 , pp. 1098-1103
    • Poupon, R.E.1    Huet, P.M.2    Poupon, R.3    Bonnand, A.M.4    Nhieu, J.T.5    Zafrani, E.S.6
  • 12
    • 0034530379 scopus 로고    scopus 로고
    • Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis
    • Almasio P.L., Floreani A., Chiaramonte M., Provenzano G., Battezzati P., Crosignani A., et al. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. Aliment Pharmacol Ther 2000, 14(12):1645-1652.
    • (2000) Aliment Pharmacol Ther , vol.14 , Issue.12 , pp. 1645-1652
    • Almasio, P.L.1    Floreani, A.2    Chiaramonte, M.3    Provenzano, G.4    Battezzati, P.5    Crosignani, A.6
  • 13
    • 0032213475 scopus 로고    scopus 로고
    • Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study
    • Wolfhagen F.H., van Hoogstraten H.J., van Buuren H.R., van Berge-Henegouwen G.P., ten Kate F.J., Hop W.C., et al. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. J Hepatol 1998, 29(5):736-742.
    • (1998) J Hepatol , vol.29 , Issue.5 , pp. 736-742
    • Wolfhagen, F.H.1    van Hoogstraten, H.J.2    van Buuren, H.R.3    van Berge-Henegouwen, G.P.4    ten Kate, F.J.5    Hop, W.C.6
  • 14
    • 0032805850 scopus 로고    scopus 로고
    • Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol
    • Bonis P.A., Kaplan M. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol. Gastroenterology 1999, 117(2):395-399.
    • (1999) Gastroenterology , vol.117 , Issue.2 , pp. 395-399
    • Bonis, P.A.1    Kaplan, M.2
  • 15
    • 0027190525 scopus 로고
    • Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone
    • Buscher H.P., Zietzschmann Y., Gerok W. Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. J Hepatol 1993, 18(1):9-14.
    • (1993) J Hepatol , vol.18 , Issue.1 , pp. 9-14
    • Buscher, H.P.1    Zietzschmann, Y.2    Gerok, W.3
  • 16
    • 1842480289 scopus 로고    scopus 로고
    • A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results
    • Kaplan M.M., Cheng S., Price L.L., Bonis P.A. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Hepatology 2004, 39(4):915-923.
    • (2004) Hepatology , vol.39 , Issue.4 , pp. 915-923
    • Kaplan, M.M.1    Cheng, S.2    Price, L.L.3    Bonis, P.A.4
  • 18
    • 43049149045 scopus 로고    scopus 로고
    • The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
    • Iwasaki S., Ohira H., Nishiguchi S., Zeniya M., Kaneko S., Onji M., et al. The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study. Hepatol Res 2008, 38(6):557-564.
    • (2008) Hepatol Res , vol.38 , Issue.6 , pp. 557-564
    • Iwasaki, S.1    Ohira, H.2    Nishiguchi, S.3    Zeniya, M.4    Kaneko, S.5    Onji, M.6
  • 19
    • 0026673728 scopus 로고
    • A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results
    • Mitchison H.C., Palmer J.M., Bassendine M.F., Watson A.J., Record C.O., James O.F. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 1992, 15(3):336-344.
    • (1992) J Hepatol , vol.15 , Issue.3 , pp. 336-344
    • Mitchison, H.C.1    Palmer, J.M.2    Bassendine, M.F.3    Watson, A.J.4    Record, C.O.5    James, O.F.6
  • 20
    • 0028355501 scopus 로고
    • Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis
    • Wolfhagen F.H., van Buuren H.R., Schalm S.W. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med 1994, 44(3):84-90.
    • (1994) Neth J Med , vol.44 , Issue.3 , pp. 84-90
    • Wolfhagen, F.H.1    van Buuren, H.R.2    Schalm, S.W.3
  • 21
    • 0030198972 scopus 로고    scopus 로고
    • Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis
    • Leuschner M., Guldutuna S., You T., Hubner K., Bhatti S., Leuschner U. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 1996, 25(1):49-57.
    • (1996) J Hepatol , vol.25 , Issue.1 , pp. 49-57
    • Leuschner, M.1    Guldutuna, S.2    You, T.3    Hubner, K.4    Bhatti, S.5    Leuschner, U.6
  • 24
    • 0032873241 scopus 로고    scopus 로고
    • Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial
    • Leuschner M., Maier K.P., Schlichting J., Strahl S., Herrmann G., Dahm H.H., et al. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 1999, 117(4):918-925.
    • (1999) Gastroenterology , vol.117 , Issue.4 , pp. 918-925
    • Leuschner, M.1    Maier, K.P.2    Schlichting, J.3    Strahl, S.4    Herrmann, G.5    Dahm, H.H.6
  • 25
    • 16244417776 scopus 로고    scopus 로고
    • Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: A three-year randomized trial
    • Rautiainen H., Karkkainen P., Karvonen A.L., Nurmi H., Pikkarainen P., Nuutinen H., et al. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: A three-year randomized trial. Hepatology 2005, 41:747-752.
    • (2005) Hepatology , vol.41 , pp. 747-752
    • Rautiainen, H.1    Karkkainen, P.2    Karvonen, A.L.3    Nurmi, H.4    Pikkarainen, P.5    Nuutinen, H.6
  • 26
    • 0033966156 scopus 로고    scopus 로고
    • Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
    • Angulo P., Jorgensen R.A., Keach J.C., Dickson E.R., Smith C., Lindor K.D. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 2000, 31(2):318-323.
    • (2000) Hepatology , vol.31 , Issue.2 , pp. 318-323
    • Angulo, P.1    Jorgensen, R.A.2    Keach, J.C.3    Dickson, E.R.4    Smith, C.5    Lindor, K.D.6
  • 28
    • 12344260987 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid
    • Talwalkar J.A., Angulo P., Keach J.C., Petz J.L., Jorgensen R.A., Lindor K.D. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. J Clin Gastroenterol 2005, 39(2):168-171.
    • (2005) J Clin Gastroenterol , vol.39 , Issue.2 , pp. 168-171
    • Talwalkar, J.A.1    Angulo, P.2    Keach, J.C.3    Petz, J.L.4    Jorgensen, R.A.5    Lindor, K.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.